Fortell venner om denne varen:
Target Validation in Drug Discovery
Dillon
Pris
R$ 758,90
Bestillingsvarer
Forventes levert 6. - 18. jun
Legg til iMusic ønskeliste
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
Media | Bøker Innbunden bok (Bok med hard rygg og stivt omslag) |
Utgitt | 1. september 2006 |
ISBN13 | 9780123693938 |
Utgivere | Elsevier Science Publishing Co Inc |
Antall sider | 296 |
Mål | 184 × 260 × 24 mm · 820 g |
Redaktør | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
Redaktør | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
Vis alle
Mer med Dillon
Andre har også kjøpt
Se alt med Dillon ( f.eks. Bok , CD , LP , Innbunden bok og Pocketbok )